SLDB
Solid Biosciences Inc.
$9.62
-0.01 (-0.10%)
At close · Jul 15
Market Cap
$887.52M
Shares
98,449,606
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$8.09M
-40.6%
FY2022
Net Income
-$174.33M
-39.8%
FY2025
Operating Margin
-1315.2%
-784.7pp
FY2022
Diluted EPS
-$1.99
+35%
FY2025
Operating Cash Flow
-$156.29M
-56.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | $8.09M | $13.62M | $0 | $0 | $0 | $0 | $0 | |
| $155.55M | $140.33M | $96.43M | $76.56M | $78.42M | $58.74M | $64.88M | $94.74M | $57.97M | $39.91M | $20.12M | |
| $40.91M | $38.88M | $33.3M | $27.75M | $28.95M | $27.14M | $21.58M | $24.58M | $17.72M | $14.95M | $5.46M | |
| — | $1.64M | $2.46M | $2.58M | $2.41M | $2.96M | $3.92M | $2.82M | — | — | — | |
| — | — | — | -$63K | $7.18M | — | $1.94M | — | — | — | — | |
| $196.46M | $179.21M | $129.73M | $104.25M | $114.55M | $85.87M | $88.41M | $119.32M | $75.69M | $54.86M | $25.58M | |
| -$196.46M | -$179.21M | -$129.73M | -$104.25M | -$106.45M | -$72.25M | -$88.41M | -$119.32M | -$75.69M | -$54.86M | -$25.58M | |
| — | — | — | — | -1315.2% | -530.5% | — | — | — | — | — | |
| — | -$177.57M | -$127.27M | -$101.67M | -$104.04M | -$69.29M | -$84.48M | -$116.49M | — | — | — | |
| — | -$203K | $340K | $440K | — | — | — | — | — | — | — | |
| $9.67M | $9.9M | $9.47M | $7.58M | $2.62M | $64K | $115K | $1.58M | $619K | $219K | $369K | |
| $4.68M | $4.88M | $5.03M | $8.24M | $20.47M | $66K | $116K | $2.1M | $889K | $1.68M | $1.8M | |
| — | -$174.2M | -$124.58M | — | — | — | — | — | — | — | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | |
| -$191.78M | -$174.33M | -$124.7M | -$96.02M | -$85.98M | -$72.19M | -$88.29M | -$117.22M | -$74.8M | -$52.12M | -$21.54M | |
| — | — | — | — | -1062.28% | -530.01% | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | $0 | -$1.06M | -$2.23M | |
| — | — | — | — | — | — | — | -$117.22M | -$74.8M | -$39.32M | -$17.23M | |
| — | — | — | — | — | — | — | -$117.22M | -$74.79M | -$52.15M | -$21.51M | |
| USD/shares | — | -$1.99 | -$3.06 | -$4.83 | -$10.10 | -$10.14 | -$25.50 | — | — | — | — |
| USD/shares | — | -$1.99 | -$3.06 | -$4.83 | -$10.10 | -$10.14 | -$25.50 | — | — | — | — |
| shares | — | 87.5M | 40.82M | 19.88M | 8.51M | 7.12M | 3.46M | 2.69M | 2.22M | 909.97K | 113.26K |
| shares | — | 87.5M | 40.82M | 19.88M | 8.51M | 7.12M | 3.46M | 2.69M | 2.22M | 909.97K | 113.26K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.53×
EV/EBIT
—
Biotechnology median 26.49×
P/E (TTM)
—
Biotechnology median 7.35×